Guillain-Barré Syndrome in Pregnancy: Risks to Mother and Fetus

GBS in pregnancy is rare (~1–2/100,000 pregnancies) but high-stakes. Immune-mediated demyelination of peripheral nerves.

Maternal Risks

  • Respiratory failure: 20–30% require intubation. Diaphragm weakness + gravid uterus reduces FRC.
  • Autonomic instability: Labile BP, arrhythmias, ileus.
  • Preterm labor: Cytokine surge, stress → 20–30% deliver <37 wks.
  • Mortality: 3–5% (vs. 1–2% non-pregnant); higher if delayed treatment.

Fetal/Neonatal Risks

  • Preterm birth complications (RDS, IVH, NEC).
  • Transplacental anti-ganglioside antibodies → transient neonatal weakness/hypotonia (rare).
  • No congenital malformations.

Management

  • IVIG 2 g/kg over 2–5 days (preferred in pregnancy; no placental transfer).
  • Plasma exchange (PLEX): Alternative; technically challenging in pregnancy.
  • Multidisciplinary team: Neurology, MFM, ICU, anesthesia, neonatology.
  • Monitoring: Serial NIF/VC, continuous telemetry, fetal surveillance.
  • Delivery planning: Vaginal preferred if stable; C-section for obstetric indications only.

Postpartum

  • Relapse risk in first 2–4 weeks.
  • Breastfeeding compatible with IVIG.
  • Rehab: PT/OT, dysautonomia management.

Early IVIG improves maternal and fetal outcomes. High index of suspicion for ascending weakness + areflexia.

Pregnancy & Health - Related Articles